0001831283-23-000094.txt : 20230623
0001831283-23-000094.hdr.sgml : 20230623
20230623162208
ACCESSION NUMBER: 0001831283-23-000094
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230621
FILED AS OF DATE: 20230623
DATE AS OF CHANGE: 20230623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS
CENTRAL INDEX KEY: 0001413822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40947
FILM NUMBER: 231037986
MAIL ADDRESS:
STREET 1: 333 ALLERTON AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LianBio
CENTRAL INDEX KEY: 0001831283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 486-2308
MAIL ADDRESS:
STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
wk-form4_1687551713.xml
FORM 4
X0407
4
2023-06-21
0
0001831283
LianBio
LIAN
0001413822
GIANAKAKOS ANASTASIOS
C/O LIANBIO
103 CARNEGIE CENTER DRIVE, SUITE 309
PRINCETON
NJ
08540
1
0
0
0
0
Stock Option (Right to Buy)
2.40
2023-06-21
4
A
0
36300
0
A
2033-06-21
Ordinary Shares
36300
36300
D
The shares underlying the option shall vest and become exercisable in full on June 21, 2024, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date.
By: /s/ Angela Chen, Attorney-in-Fact
2023-06-23